The effects of no synthesis inhibition on the uptake of endogenous nucleosides into the rat brain

被引:0
作者
Redzic, ZB
Gasic, JM
Markovic, ID
Vojvodic, VP
Vranic, VP
Jovanovic, SS
Rakic, LM
机构
[1] Sch Med, Inst Biochem, Belgrade, Yugoslavia
[2] Fac Biol, Inst Physiol, Belgrade, Yugoslavia
[3] ICN Yugoslavia Inst, Belgrade, Yugoslavia
关键词
brain uptake; endogenous nucleosides; rat; NO; NO synthesis inhibition; L-omega-nitro-arginine methyl ester (L-NAME); diphenyletiodonium;
D O I
10.1002/(SICI)1520-6769(199801/02)22:1<11::AID-NRC3>3.0.CO;2-V
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain uptake of H-3 endogenous nucleosides in rats was measured by Brain Uptake Index method, using C-14-sucrose as a referent molecule. The values obtained in control group were 4.68+/-0.93 for adenosine, 4.10+/-0.72 for guanosine and 1.14+/-0.72 for thymidine, indicating significant blood-to-brain transport of purine nucleosides. NO-synthase inhibition was induced by i.p. application of 25mg/kg 1-omega-nitro-arginin methyl ester (L-NAME) and 5mg/kg diphenylethiodonium (brain parenchyma NOS inhibitor). HPLC analysis showed that the concentration of L-NAME in brain was sufficient to cause inhibition of NOS. Application of L-NAME resulted in significant inhibition of brain uptake for both purine nucleosides. Unlike adenosine, in the case of guanosine a correlation between the rate of brain uptake inhibition and the L-NAME concentration in plasma, but not in brain, was obtained. Application of diphenylethiodonium also caused a significant decrease in both guanosine and adenosine brain uptake. The obtained results were not significantly different from the BUI values obtained after preapllication of L-NAME. Our results suggest that NOS inhibition decreases brain uptake of purine nucleosides. Such effect(s) are probably due to the inhibition of brain parenchyma NOS.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 26 条
[1]   NITRIC-OXIDE SYNTHESIZED FROM L-ARGININE REGULATES VASCULAR TONE IN THE CORONARY CIRCULATION OF THE RABBIT [J].
AMEZCUA, JL ;
PALMER, RMJ ;
DESOUZA, BM ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (04) :1119-1124
[2]   ASTROCYTES - TARGETS AND MEDIATORS OF CHEMICAL-INDUCED CNS INJURY [J].
ASCHNER, M ;
LOPACHIN, RM .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1993, 38 (03) :329-342
[3]  
BORGERDING RA, 1995, J NEUROCHEM, V65, P1342, DOI 10.1046/j.1471-4159.1995.65031342.x
[4]  
BRUHWYLER A, 1993, NEUROSCI BIOBEHAV RE, V17, P373
[5]   EFFECTS OF INHIBITION OF NITRIC-OXIDE SYNTHASE ON BLOOD-BRAIN-BARRIER TRANSPORT IN FOCAL CEREBRAL-ISCHEMIA [J].
CHI, OZ ;
WEI, HM ;
SINHA, AK ;
WEISS, HR .
PHARMACOLOGY, 1994, 48 (06) :367-373
[6]  
CORFORD EM, 1975, BIOCHIM BIOPHYS ACTA, V394, P211
[7]   PHYSIOLOGICAL AND PHARMACOLOGICAL PROPERTIES OF ADENOSINE - THERAPEUTIC IMPLICATIONS [J].
DAVAL, JL ;
NEHLIG, A ;
NICOLAS, F .
LIFE SCIENCES, 1991, 49 (20) :1435-1453
[8]  
DAVSON H, 1996, PHYSL CSF BLOOD BRAI, P59
[9]  
DAWSON VL, 1993, J NEUROSCI, V13, P2651
[10]   ISOLATION OF HTLV-III FROM CEREBROSPINAL-FLUID AND NEURAL TISSUES OF PATIENTS WITH NEUROLOGIC SYNDROMES RELATED TO THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
HO, DD ;
ROTA, TR ;
SCHOOLEY, RT ;
KAPLAN, JC ;
ALLAN, JD ;
GROOPMAN, JE ;
RESNICK, L ;
FELSENSTEIN, D ;
ANDREWS, CA ;
HIRSCH, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (24) :1493-1497